ZEB1 expression in type I vs type II endometrial cancers: A marker of aggressive disease

Modern Pathology

Volumn 21, Issue 7, 2008, Pages 912-923

  Singh, Meenakshi ^a   Spoelstra, Nicole S ^a   Jean, Annie ^a   Howe, Erin ^a   Torkko, Kathleen C ^a   Clark, Hilda R ^a   Darling, Douglas S ^b   Shroyer, Kenneth R ^a   Horwitz, Kathryn B ^a,c   Broaddus, Russell R ^d   Richer, Jennifer K ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

EF1; E cadherin; Epithelial to mesenchymal transition; Type I and type II endometrial cancer; ZEB1; Zfhx1a

Indexed keywords

TRANSCRIPTION FACTOR; UVOMORULIN; ZINC FINGER E BOX BINDING HOMEOBOX 1;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENDOMETRIUM CANCER; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, ENDOMETRIOID; CELL LINE, TUMOR; DISEASE PROGRESSION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HOMEODOMAIN PROTEINS; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 46049120814     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.82     Document Type: Article

References (30)

1. Smith GE, Darling DS. Combination of a zinc finger and homeodomain required for protein-interaction. Mol Biol Rep 2003;30:199-206.
2. Fontemaggi G, Gurtner A, Strano S, et al. The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation. Mol Cell Biol 2001;21:8461-8470.
3. Ikeda K, Kawakami K. DNA binding through distinct domains of zinc-finger-homeodomain protein AREB6 has different effects on gene transcription. Eur J Biochem 1995;233:73-82.
4. Darling DS, Stearman RP, Qi Y, et al. Expression of Zfhep/deltaEF1 protein in palate, neural progenitors, and differentiated neurons. Gene Expr Patterns 2003;3:709-717.
5. Funahashi J, Sekido R, Murai K, et al. Delta-crystallin enhancer binding protein delta EF1 is a zinc finger-homeodomain protein implicated in postgastrulation embryogenesis. Development 1993;119:433-446.
6. Higashi Y, Moribe H, Takagi T, et al. Impairment of T cell development in deltaEF1 mutant mice. J Exp Med 1997;185:1467-1479.
7. Takagi T, Moribe H, Kondoh H, et al. DeltaEF1, a zinc finger and homeodomain transcription factor, is required for skeleton patterning in multiple lineages. Development 1998;125:21-31.
8. Murray D, Precht P, Balakir R, et al. The transcription factor deltaEF1 is inversely expressed with type II collagen mRNA and can repress Col2a1 promoter activity in transfected chondrocytes. J Biol Chem 2000;275:3610-3618.
9. Terraz C, Toman D, Delauche M, et al. Delta Ef1 binds to a far upstream sequence of the mouse pro-alpha 1(I) collagen gene and represses its expression in osteoblasts. J Biol Chem 2001;276:37011-37019.
10. Yen G, Croci A, Dowling A, et al. Developmental and functional evidence of a role for Zfhep in neural cell development. Brain Res Mol Brain Res 2001;96:59-67.
11. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007;7:415-428.
12. Eger A, Aigner K, Sonderegger S, et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005;17:17.
13. Guaita S, Puig I, Franci C, et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 2002;277:39209-39216.
14. Ohira T, Gemmill RM, Ferguson K, et al. WNT7a induces E-cadherin in lung cancer cells. Proc Natl Acad Sci USA 2003;100:10429-10434.
15. Aigner K, Dampier B, Descovich L, et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007;26:6979-6988.
16. Aigner K, Descovich L, Mikula M, et al. The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression. FEBS Lett 2007;581:1617-1624.
17. Spoelstra NS, Manning NG, Higashi Y, et al. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Res 2006;66:3893-3902.
18. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10-17.
19. Ryan AJ, Susil B, Jobling TW, et al. Endometrial cancer. Cell Tissue Res 2005;322:53-61.
20. Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 2004;48:365-375.
21. Formby B, Wiley TS. Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosis. Mol Cell Biochem 1999;202:53-61.
22. Costantino ME, Stearman RP, Smith GE, et al. Cell-specific phosphorylation of Zfhep transcription factor. Biochem Biophys Res Commun 2002;296:368-373.
23. Balmer NN, Richer JK, Spoelstra NS, et al. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: correlation with clinicopathologic parameters and biomarkers. Mod Pathol 2006;19:1593-1605.
24. Albitar L, Pickett G, Morgan M, et al. Models representing type I and type II human endometrial cancers: Ishikawa H and Hec50coco cells. Gynecol Oncol 2007;106:52-64.
25. Gotzmann J, Mikula M, Eger A, et al. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 2004;566:9-20.
26. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-549.
27. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-454.
28. Shirakihara T, Saitoh M, Miyazono K. Differential regulation of epithelial and mesenchymal markers by {delta}EF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol Biol Cell 2007;18:3533-3544.
29. Krishnamachary B, Zagzag D, Nagasawa H, et al. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 2006;66:2725-2731.
30. Hurteau GJ, Carlson JA, Spivack SD, et al. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res 2007;67:7972-7976.